Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Blood Gas Analyzers Market: By Product, By Application and Others) and Geography
Blood Gas Analyzers Market: By Product, By Application and Others) and Geography
Blood Gas Analyzers Market size is accounted for US$ 765.5 million in 2023 and is poised to grow at a CAGR of 5.2% from 2024 to 2030. Blood gas analysis has proven to be an effective diagnostic technique in critical care, pre-hospital and in-hospital emergency treatment. With the advent sensor technology, blood gas testing has become more accessible to patients. Respiratory therapists play a vital role for blood gas analysis at its center. Surge in the demand for technology-integrated systems and point-of-care devices is anticipated to fuel the blood gas analyzers market. Blood gas analyzers are the analytical instruments that are used in measuring the blood gas (pCO2 and pO2), electrolytes, metabolites, and the combinations opH from the blood samples.
The conservation of blood is the major initiative in the clinical diagnostic lab, which need an accurate blood gas analyzer that can streamline the process of work and help in reduction of the errors with minimal maintenance. Blood gas analyzers are available in a lightweight and in small footprint design. Most models offer simple replacement of the solutions for the analysis such as solution packs and sensor cassettes. There are certain unique features to some of the blood gas analyzers such as liquid calibration which replaces previously required regulators, humidifiers, tubing lines and gas tanks.
Study Period
2024-2030Base Year
2023CAGR
5.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Increased prevalence of chronic diseases such as diabetes and other cardiovascular disorders is expected to increase the demand for blood gas analyzers. Surge in the prevalence of chronic diseases due to aging population and socioeconomic changes are contributing to long-term health issues. Sedentary lifestyle coupled with dramatic changes in the dietary habits are major factors, which drives the prevalence of diabetic population. Moreover, increased obesity rates lead to multiple chronic disorders. In accordance with World Health Organization (WHO), chronic disease prevalence is anticipated to climb by 57 percent by 2020. However, high cost of analyzers and limited reimbursement are inhibiting the market growth.
North America blood gas analyzers market has registered the highest revenue share in 2021 and is expected to continue its dominance in the future. The demand for blood gas analyzers is expected to boost due to presence of sophisticated domestic and international medical device manufacturers in the region. Furthermore, medical tourism is expected to attract the patients from all over the world due to presence of state-of-art healthcare infrastructure in The inclination towards Point-of-Care devices is expected to fuel the demand for PoC Blood gas analyzers in the future. Europe is predicted to have a considerable market share during the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 765.5 million |
|
Market CAGR |
5.2% |
|
By Product Type |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The global blood gas analyzers market size was valued at US$ 765.5 million in 2023 and is projected to grow at a CAGR of 5.2% from 2024 to 2030.
The blood gas analyzers market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The blood gas analyzers market key players are: Abbott Laboratories, Danaher Corporation (Radiometer), Hoffmann-La Roche AG, IDEXX Laboratories,Inc. (OptiMedicalSystems,Inc.), Medica Corporation, Nova Biomedical
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.